Skip to content
10-K

Annual Report

Apollo Endosurgery, Inc.

0001251769-23-000006

← back to feed
Filed
Mar 30, 2023 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 15, 2023 57.97M sh
Shares Diluted FY 2022 · Dec 31, 2022 40.65M sh
Shares Diluted FY 2022 · Dec 31, 2021 30.24M sh
Capex FY 2022 · Dec 31, 2022 $2.27M
Capex FY 2022 · Dec 31, 2021 $1.2M
Operating Cash Flow FY 2022 · Dec 31, 2022 −$31.26M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$14.45M
Long Term Debt FY 2022 · Dec 31, 2022 $33.96M
Long Term Debt FY 2022 · Dec 31, 2021 $33.47M
Cash And Equivalents FY 2022 · Dec 31, 2022 $57M
Cash And Equivalents FY 2022 · Dec 31, 2021 $90.69M
Stockholders Equity FY 2022 · Dec 31, 2022 $32.59M
Stockholders Equity FY 2022 · Dec 31, 2021 $61.24M
Stockholders Equity FY 2022 · Dec 31, 2020 $6.75M
Current Liabilities FY 2022 · Dec 31, 2022 $39.54M
Current Liabilities FY 2022 · Dec 31, 2021 $14.49M
Total Liabilities FY 2022 · Dec 31, 2022 $77.64M
Total Liabilities FY 2022 · Dec 31, 2021 $70.29M
Current Assets FY 2022 · Dec 31, 2022 $92.88M
Current Assets FY 2022 · Dec 31, 2021 $114.7M
Total Assets FY 2022 · Dec 31, 2022 $110.23M
Total Assets FY 2022 · Dec 31, 2021 $131.53M
Eps Diluted FY 2022 · Dec 31, 2022 −$0.98
Eps Diluted FY 2022 · Dec 31, 2021 −$0.82
Eps Basic FY 2022 · Dec 31, 2022 −$0.98
Eps Basic FY 2022 · Dec 31, 2021 −$0.82
Sga Expense FY 2022 · Dec 31, 2022 $20.58M
Sga Expense FY 2022 · Dec 31, 2021 $18.45M
Rd Expense FY 2022 · Dec 31, 2022 $11.91M
Rd Expense FY 2022 · Dec 31, 2021 $9.52M
Net Income FY 2022 · Dec 31, 2022 −$39.84M
Net Income FY 2022 · Dec 31, 2021 −$24.68M
Operating Income FY 2022 · Dec 31, 2022 −$31.42M
Operating Income FY 2022 · Dec 31, 2021 −$19.2M
Gross Profit FY 2022 · Dec 31, 2022 $42.43M
Gross Profit FY 2022 · Dec 31, 2021 $34.96M
Revenue FY 2022 · Dec 31, 2022 $76.86M
Revenue FY 2022 · Dec 31, 2021 $62.99M